When Should Ovulation Be Suppressed in Hens?

By: Tricia Young


Keywords:
Hen Ovulation Suppression
Reproductive disease
Egg Yolk Peritonitis
Salpingitis
Deslorelins Suprelorin Implant
Hen Ovarian Neoplasm
Egg Yolk Coelomitis
Leuprolide (Lupron) Injection


Introduction
Ovulation suppression has become an increasingly important tool in the management of reproductive disease in hens. One of the most common questions asked by caretakers and veterinarians is simple: when should ovulation be suppressed?
Some recommendations suggest initiating ovulation suppression according to a fixed timeline. However, hens vary widely in egg production, reproductive biology, and individual health history. Because of these differences, a single timeline may not be appropriate for every bird.
Modern laying chickens have been selectively bred to produce large numbers of eggs each year. Each egg represents an ovulatory event. Over time, repeated ovulation places mechanical and inflammatory stress on reproductive tissues.
Understanding when ovulation suppression may be beneficial requires considering the reproductive workload experienced by the individual hen. For the hen that already has reproductive disease, it is particularly important to watch for signs rather then follow "typical" protocols because any lapse in suppression will advance disease.


Why Ovulation Matters
Each egg laid by a hen begins with ovulation — the release of a yolk from the ovary.
While ovulation is a normal biological process, repeated ovulation increases the number of times reproductive tissues are exposed to potential irritation and inflammation.
Repeated ovulation increases the likelihood that:
• yolk may escape the reproductive tract
• abdominal tissues may become inflamed
• infection may develop within the oviduct
• abnormal tissue changes may occur in reproductive organs
Because ovulation occurs with each egg produced, hens that lay more eggs experience many more ovulatory cycles over time.


Differences in Egg Production
Selective breeding has produced chickens with widely different egg production rates.
Type
Examples
Typical Eggs per Year
Wild ancestorRed Junglefowl~10-15
Heritage breedsPlymouth Rock, Sussex, Wyandotte~180-220
High-production hybridsGolden Comet, ISA Brown, Red Star~280-320
Low-production bantamsSebright, Silkie, Pekin bantam~60-120

Lifetime Ovulation Burden
The total number of ovulations a hen experiences during her life varies dramatically depending on egg production.
Example:

Low-production hen
80 eggs per year × 5 years ≈ 400 ovulations
High-production hybrid
300 eggs per year × 2 years ≈ 600 ovulations
Although lower-production hens lay fewer eggs each year, a longer reproductive lifespan may still result in substantial ovulation over time.
Considering lifetime ovulation burden helps place reproductive disease risk in context.


How Ovulation Suppression Works
Ovulation suppression medications interfere with hormonal signals that regulate the reproductive cycle.
In a normal hen, hormonal signals stimulate the ovary to mature follicles and release yolks.
Medications such as deslorelin implants or leuprolide injections interrupt these signals. As ovarian activity decreases, ovulation slows or stops.
When ovulation stops, new yolks are no longer released into the reproductive tract. This reduces the number of ovulatory cycles experienced by the hen and decrease ongoing stress on reproductive tissues, and the liver.


Methods of Ovulation Suppression
Deslorelin Implants

Deslorelin implants slowly release medication that suppresses ovarian stimulation.
Because the medication is released gradually, implants may suppress ovulation for several months. The duration of suppression varies between individual hens.


Possible Side Effects
Deslorelin implants are generally well tolerated. Possible side effects may include:
· Significant molting
· Temporary weight loss
· Possible swelling at the implant site for 1-2 weeks
· Reduced appetite
· Changes in behavior/personality, often more meek



Leuprolide (Lupron) Injections
Leuprolide injections suppress ovulation through a similar hormonal mechanism but require repeated dosing.
A commonly used protocol includes:
• three injections given 2–3 weeks apart
• followed by monthly injections
It is important to understand that ovulation suppression usually does not occur until the third injection.
Because multiple injections are required before suppression begins, this method may be more expensive and less convenient for long-term management.

Possible Side Effects
Possible side effects may include:
• Possible bone loss
• temporary hormonal stimulation before suppression begins
• continued egg laying during the initial treatment period
Careful observation during the early treatment phase is recommended.


Implant Placement
Deslorelin implants are placed subcutaneously, just beneath the skin.
Two common placement locations include:
• the interscapular region between the shoulders
• the superficial tissues over the pectoral muscle near the keel
The implant is placed very superficially and does not need to be inserted deeply into tissue. The procedure is similar to placing a microchip in a dog or cat.


Early Signs of Reproductive Disease

Some hens may show subtle changes before more advanced disease develops.

Possible early signs include:

  • Decreased activity

  • Abnormal looking eggs

  • Not laying eggs

  • Yellow colored dropping

  • Excessive nesting box sitting

  • Laying lash eggs

  • Lethargy

  • Ascites (a late-stage symptom)

  • Reluctance to jump onto perches

  • Changes in posture – Penguin stance

  • Abdominal enlargement

  • Weight loss

  • Increased breathing effort while resting

  • Recurrent respiratory symptoms

  • Inflammatory material within the abdomen may compress the air sacs, making breathing less efficient.

Clinical Decision Framework

Decisions regarding ovulation suppression should consider both the baseline ovulation burden of the hen and the presence of reproductive disease.

Some hens may benefit from ovulation suppression as a preventative measure, while others may receive suppression after disease has already developed.



Prophylactic Decision Tree

Hen laying 3 or more eggs per week


High ovulation burden likely


Approaching 2 years of age


Discuss ovulation suppression with a veterinarian

Early Symptoms Decision Tree

Early signs of reproductive disease:

Veterinary evaluation


Antibiotics and anti-inflammatory treatment if indicated


Drain abdominal fluid if necessary


Consider ovulation suppression

Re-Implantation

Deslorelin implants gradually release medication over time. The duration of suppression varies between hens and may be influenced by factors such as metabolism, egg production rate, and implant dose. Many guidelines publish 3-6 months for the 4.7mg and 6-9 months for the 9.4mg. However, these guidelines make many assumptions; the hen is not high-production and the hen does not have active reproductive disease. The results in these two categories indicate durations in between implants to be shorter.

Because the duration of effect is variable, hens should be monitored for signs that ovarian activity is returning.

Risk–Benefit Considerations

The decision to suppress ovulation should balance potential benefits with the individual circumstances of the hen.

Hens that lay frequently may experience greater lifetime ovulation burden and may benefit from earlier suppression.

Lower-production breeds may have a lower baseline risk of ovulation-related disease. However, once reproductive disease develops, suppression may still reduce continued reproductive stress.

Factors that may influence the decision include:

• egg production rate

• breed and genetic background

• age of the hen

• history of reproductive disease

• current clinical signs

Veterinary guidance can help determine whether ovulation suppression is appropriate for an individual bird.

Conclusion

Ovulation suppression can be an important tool in protecting reproductive health in hens. However, the appropriate timing of suppression varies widely between individual hens.

Considering egg production rate, lifetime ovulation burden, and early clinical signs allows caretakers and veterinarians to make more informed decisions about when ovulation suppression may provide the greatest benefit.

References

Etches, R. J. (1996). Reproduction in Poultry. CAB International.



Johnson, A. L. (2015). Ovarian follicle selection and development in the chicken. Poultry Science, 94(4), 781–785.



Romanoff, A. L., & Romanoff, A. J. (1949). The Avian Egg. Wiley.



Hafez, B., & Hafez, E. (2000). Reproduction in Farm Animals (7th ed.). Lippincott Williams & Wilkins.



Sturkie, P. D. (2015). Sturkie’s Avian Physiology (6th ed.). Academic Press.



Doneley, B. (2016). Avian Medicine and Surgery in Practice: Companion and Aviary Birds. CRC Press.



Speer, B. L. (2015). Current Therapy in Avian Medicine and Surgery. Elsevier.



Harrison, G. J., & Lightfoot, T. (2006). Clinical Avian Medicine. Spix Publishing.



Petritz, O. A., et al. (2014). Use of deslorelin implants in avian species. Journal of Avian Medicine and Surgery.